Schedule 13G ownership disclosure

Corbus Pharmaceuticals Holdings Inc

Common Stock · CUSIP: 21833P301

Event date: 2025-06-30

Filing-level shares
599,495
Percent of class
4.89%
  • The Vanguard Group

    Shares: 599,495 · Class: 4.89%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000833
Form type
SCHEDULE 13G/A
Filer
Corbus Pharmaceuticals Holdings, Inc.
CIK
CIK 1595097
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub